Side effects of glipizide metformin
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Glipizide and Metformin Combination Therapy
Introduction to Glipizide and Metformin
Glipizide and metformin are commonly used medications for managing type 2 diabetes. Glipizide is a sulfonylurea that stimulates insulin secretion, while metformin primarily reduces hepatic glucose production and improves insulin sensitivity. When used together, these drugs can effectively lower blood glucose levels, but they also come with potential side effects.
Common Side Effects of Glipizide
Hypoglycemia
One of the most significant side effects of glipizide is hypoglycemia, which is a condition characterized by abnormally low blood glucose levels. Studies have shown that patients treated with glipizide experience a higher incidence of hypoglycemia compared to other treatments. For instance, in a 52-week trial, 40.8% of patients on glipizide experienced hypoglycemia compared to only 3.5% on dapagliflozin .
Weight Gain
Glipizide is also associated with weight gain. In the same study, patients on glipizide gained an average of 1.2 kg over 52 weeks, whereas those on dapagliflozin lost weight . This weight gain can be a concern for patients who are already managing obesity or other weight-related health issues.
Cardiovascular Risks
Long-term use of glipizide has been linked to adverse cardiovascular outcomes. A study comparing glipizide and metformin found that metformin significantly reduced the risk of major cardiovascular events compared to glipizide . This suggests that glipizide may pose higher cardiovascular risks, especially in patients with a history of coronary artery disease.
Common Side Effects of Metformin
Gastrointestinal Issues
Metformin is well-known for causing gastrointestinal side effects such as nausea, vomiting, diarrhea, and abdominal discomfort. These symptoms are usually transient and can often be managed by adjusting the dosage or taking the medication with food .
Lactic Acidosis
Although rare, lactic acidosis is a serious side effect of metformin. This condition is characterized by the buildup of lactic acid in the blood and can be life-threatening. It is more likely to occur in patients with renal impairment or other conditions that predispose them to lactic acid accumulation .
Combined Therapy: Glipizide and Metformin
Hypoglycemia and Nervous System Side Effects
When used in combination, glipizide and metformin can increase the risk of hypoglycemia and nervous system side effects. A meta-analysis found that the combination therapy significantly increased the risk of hypoglycemia and nervous system side effects compared to metformin alone .
Lipid Profile and Insulin Levels
The combination of glipizide and metformin has been shown to affect lipid profiles and insulin levels. For example, glipizide plus metformin significantly increased fasting insulin levels and slightly reduced HDL cholesterol . These changes can have implications for cardiovascular health and overall metabolic control.
Weight and Fibrinolytic Parameters
Interestingly, the combination therapy does not seem to cause significant weight gain. A study found that adding glipizide to metformin did not produce any significant or clinically relevant weight gain or changes in BMI . Additionally, both drugs, when used together, have been shown to reduce elevated plasminogen-activated inhibitor 1 (PAI-1) levels, which are markers of cardiovascular risk .
Conclusion
While the combination of glipizide and metformin is effective in managing blood glucose levels in type 2 diabetes, it comes with a range of side effects. Hypoglycemia and weight gain are significant concerns with glipizide, while metformin is more likely to cause gastrointestinal issues and, rarely, lactic acidosis. When used together, these drugs can increase the risk of hypoglycemia and affect lipid profiles and insulin levels. Therefore, it is crucial for healthcare providers to carefully monitor patients on this combination therapy to manage and mitigate these side effects effectively.
Sources and full results
Most relevant research papers on this topic